|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Current assets | ||||
| Cash | ||||
| Prepaid expense | ||||
| Deferred offering cost | ||||
| Total current assets | ||||
| Marketable securities held in trust account | ||||
| TOTAL ASSETS | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||
| Current liabilities | ||||
| Accounts payable | ||||
| Accrued offering costs | ||||
| Promissory note | ||||
| Total current liabilities | ||||
| TOTAL LIABILITIES | ||||
| Class A ordinary shares; $0.0001 par value, subject to possible redemption, 22,750,000 shares at redemption value | ||||
| STOCKHOLDERS' EQUITY | ||||
| Common stock | ||||
| Class A ordinary share | ||||
| Class B ordinary share | ||||
| Additional paid in capital | ||||
| Retained earning/Accumulated deficit | ||||
| Total Stockholders' Equity | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...